Nicotine Lozenge
Product Images NDC 11822-0905

1 FDA label image from Rite Aid Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Nicotine (NDC 11822-0905). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rite Aid Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nicotine Polacrilex 4 mg (Nicotine Polacrilex 4 mg Cinnamon Lozenge 1)

Nicotine Polacrilex 4 mg (Nicotine Polacrilex 4 mg Cinnamon Lozenge 1)
Drug Facts for Nicotine Polacrilex Lozenges 4 mg include active ingredient, usage instructions for quitting smoking, warnings, directions for use, inactive ingredients, and storage information. The panel also has detailed advice on dosage schedules and safety precautions, including conditions when to consult a doctor or pharmacist.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.